Newsfeeds - Spark Newswire

1 minute read

Contracts
M&A
News

AEON Biopharma, Priveterra Acquisition Announce Filing Of S-4 Registration Statement For Proposed Business Combination

Today, 9:37 PM

https://www.aeonbiopharma.com/2023/01/aeon-biopharma-and-priveterra-acquisition-corp-announce-filing-of-s-4-registration-statement-for-proposed-business-combination-2/

PMGM

1 minute read

AEON Biopharma And Priveterra Acquisition Corp. Announce Filing Of S-4 Registration Statement For Proposed Business Combination

By Benzinga Newsdesk

Today, 9:37 PM

AEON Biopharma, Inc. ("AEON" or the "Company"), a clinical-stage biopharmaceutical company developing a proprietary botulinum toxin for the treatment of multiple debilitating medical conditions, and

PMGM

Latest news

AEON Biopharma, Priveterra Acquisition Announce Filing Of S-4 Registration Statement For Proposed Business Combination

AEON Biopharma And Priveterra Acquisition Corp. Announce Filing Of S-4 Registration Statement For Proposed Business Combination